Viemed Healthcare Insider Buys 10,000 Shares
William Frazier, CMO of Viemed Healthcare, purchased 10,000 shares on June 25.
Key Points
- William Frazier, Viemed Healthcare's Chief Medical Officer, purchased 10,000 shares on June 25, 2026, for $18,100.
- Viemed Healthcare has a market cap of approximately $445.9 million and a P/E ratio of 31.43.
- Vanguard Capital Management opened a new position in Viemed Healthcare, holding 1,303,384 shares valued at about $12 million.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
On June 25, 2026, William Frazier, the Chief Medical Officer of Viemed Healthcare, Inc. (NasdaqCM: VMD), purchased 10,000 shares of the company at an average price of $1.81 per share. This transaction was valued at $18,100 and was not part of a pre-arranged trading plan.
Insider Buying and Selling at Viemed Healthcare, Inc.
In addition to William Frazier's purchase, there was notable insider activity on the same date. Frazier also sold 10,000 shares at an average price of $11.72, and another 10,000 shares without a recorded price, indicating active trading. Timothy Smokoff sold 20,000 shares at an average price of $11.50 on June 24, 2026. Earlier in March, Michael Moore, the President, sold 65,000 shares at $8.77 and 40,232 shares at $9.21.
Other Institutional Activity in Viemed Healthcare
In recent institutional activity, Vanguard Capital Management LLC opened a new position in Viemed Healthcare, holding 1,303,384 shares worth approximately $12 million. Meanwhile, Ameriprise Financial Inc increased its holdings by 75,506 shares, ending with 898,319 shares valued at about $8.27 million, a 9.2% increase. Forager Capital Management LLC also grew its stake by 40,000 shares to a total of 2,825,871 shares, valued at $26.03 million. Conversely, Nantahala Capital Management, LLC reduced its position by 48,662 shares, holding 883,783 shares worth $8.14 million, a 5.2% decrease.
Viemed Healthcare, Inc. Stock Up 31.9%
Shares of Viemed Healthcare traded near $11.63 on Sunday. The company has a market capitalization of approximately $445.9 million and a P/E ratio of 31.43. Viemed's stock has ranged from a low of $5.93 to a high of $11.88 over the past 52 weeks. The stock's 50-day moving average is $9.89, while its 200-day moving average is $8.19. The company maintains a current ratio of 1.22 and a quick ratio of 1.01, with a debt-to-equity ratio of 8.53.
$VMD stock price
Daily closing prices, year to date. Not investment advice.
Recent Earnings
Viemed Healthcare reported revenue of $286.6 million, with a revenue growth rate of 27.5%. The company's earnings per share stand at $0.37, reflecting a net margin of 5.2% and a return on equity of 10.9%. The next earnings report is scheduled for August 5, 2026.
Analysts Set New Price Targets
Lake Street reiterated its buy rating for Viemed Healthcare, setting a price target of $15.00 on May 7, 2024. The consensus among analysts is a buy rating, with a mean target price of $11.00.
About Viemed Healthcare
Viemed Healthcare, Inc. specializes in providing home medical equipment and post-acute respiratory healthcare services across the United States. Based in Lafayette, Louisiana, the company offers a range of respiratory disease management solutions, including non-invasive ventilation and oxygen therapy. Under the leadership of CEO Casey Hoyt, Viemed also provides sleep apnea management and related equipment, employing around 1,387 people.
Bottom Line
William Frazier's recent purchase of Viemed Healthcare shares highlights ongoing insider activity within the company. Investors often track such transactions for potential insights into company confidence. As always, it's important to remember that insider trades are just one piece of the puzzle and may not reflect the company's current financial position or future outlook.
Get Viemed Healthcare, Inc. alerts
New 13F filings, insider trades, and analyst moves on $VMD, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.